(Glyco)-protein drug carriers with an intrinsic therapeutic activity: The concept of dual targeting
References (26)
- et al.
Targeting of drugs to various blood cell types using (neo)-glycoproteins, antibodies and other protein carriers
Adv. Drug Deliv. Rev.
(1994) - et al.
Drug targeting to the kidney with low molecular weight proteins
Adv. Drug Deliv. Rev.
(1994) - et al.
Renal specific delivery of sulfamethoxazole in the rat by coupling to the low molecular weight protein lysozyme via an acid-sensitive linker
Int. J. Pharm.
(1992) - et al.
Hepatic endocytosis of various types of mannose-terminated albumins
- et al.
Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and Kupffer cells of the liver: evidence for scavenger receptor heterogeneity
Biochem. Biophys. Res. Commun.
(1991) - et al.
Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules
Biochem. Pharmacol.
(1993) - et al.
Targeting of antiviral drugs to T4-lymphocytes
- et al.
Simultaneous analysis of azidothymidine and its mono-, di-and triphosphate derivatives in biological fluids, tissue and cultured cells by a rapid high-performance liquid chromatographic method
J. Chromatogr.
(1992) - et al.
Drug targeting systems for antiviral agents: options and limitations
Antiviral Res.
(1992) - et al.
Covalent and noncovalent protein binding of drugs: Implications for hepatic clearance, storage, and cell-specific drug delivery
Pharm. Res.
(1989)
Design of cell-specific drug targeting preparations for the liver: where cell biology and medicinal chemistry meet
Disposition of macromolecules in the liver in relation to drug targeting
Mechanisms for the hepatic clearance of oligopeptides and proteins
Cited by (0)
Copyright © 1996 Published by Elsevier B.V.